ClinicalTrials.Veeva

Menu
I

Instituto Brasil de Pesquisa Clinica | Rio de Janeiro, Brazil

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

BI 456906
Semaglutide
Survodutide
Guselkumab
Golimumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 5 total trials

A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)

This study is open to adults who are at least 18 years old and have a body mass index (BMI)bof 27 kg/m2 or more. People can take part if they have ca...

Enrolling
Obesity
Drug: Placebo
Drug: survodutide

Trial sponsors

Novo Nordisk logo
Boehringer Ingelheim logo
Janssen (J&J Innovative Medicine) logo
Janssen (J&J Innovative Medicine) logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems